208190-04-9

Basic information

• Product Name: 3-Pyrid-4-ylbenzaldehyde
• Synonyms: 3-PYRID-4-YLBENZALDEHYDE;3-PYRIDIN-4-YL-BENZALDEHYDE;3-(4-PYRIDINYL)BENZALDEHYDE;3-(4-PYRIDYL)BENZALDEHYDE;AKOS BAR-0608;3-(Pyridin-4-yl)benzaldehyde 97%;3-(3-Fluoropyridin-4-yl)benzaldehyde;3-PYRIDIN-4-YL-BENZALDEHYDE, 95+%
• CAS NO: 208190-04-9
• Molecular Formula: C₁₂H₉NO
• Molecular Weight: 183.21
• Mol File: 208190-04-9.mol
• Article Data: 10

Chemical Properties

• Melting Point: 48 °C
• Boiling Point: 341.786 °C at 760 mmHg
• Flash Point: 168.462 °C
• Appearance: /
• Density: 1.148 g/cm³
• Vapor Pressure: 5.84E-05mmHg at 25°C
• Refractive Index: 1.555
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 4.72±0.26(Predicted)
• CAS DataBase Reference: 3-Pyrid-4-ylbenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyrid-4-ylbenzaldehyde(208190-04-9)
• EPA Substance Registry System: 3-Pyrid-4-ylbenzaldehyde(208190-04-9)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 22-36/37/38-36
• Safety Statements: 22-26-36/37/39
• Hazardous Substances Data: 208190-04-9(Hazardous Substances Data)

Usage

General Description

3-Pyrid-4-ylbenzaldehyde is a chemical compound composed of a benzene ring with a pyridine ring attached at the fourth carbon atom and an aldehyde group at the first position of the benzene ring. It is a pale yellow solid with a molecular formula of C12H9NO and a molecular weight of 183.21 g/mol. 3-Pyrid-4-ylbenzaldehyde is used as a key intermediate in the synthesis of various pharmaceuticals, agrochemicals, and dyes. Additionally, it exhibits potential biological activities, including antimicrobial, antifungal, and anti-inflammatory properties, making it a valuable compound for research purposes. However, it is important to handle 3-Pyrid-4-ylbenzaldehyde with caution as it may be hazardous if not properly managed.

InChI:InChI=1/C11H15NOS/c1-13-10-4-2-9(3-5-10)11-8-14-7-6-12-11/h2-5,11-12H,6-8H2,1H3

Upstream product

• 1120-87-2 4-bromopyridin 
• 87199-16-4 3-Formylphenylboronic acid 
• 3132-99-8 m-bromobenzoic aldehyde 
• 1692-15-5 4-pyridylboronic acid 
• 19524-06-2 4-bromopyridine hydrochloride 

Downstream Products

• 1060977-97-0 C₂₃H₃₁N₃O₂ 
• 1396789-65-3 C₃₅H₃₈ClN₃O₂S 
• 1396789-66-4 C₃₅H₃₄ClN₃O₂S₂ 
• 1396789-67-5 C₃₈H₃₅ClN₄O₂S 
• 1401533-26-3 tert-butyl 4-[(3-pyridin-4-ylbenzyl)amino]piperidine-1-carboxylate 
• 1401532-90-8 3-chloro-N-piperidin-4-yl-N-(3-pyridin-4-ylbenzyl)benzo[b]thiophene-2-carboxamide 
• 1401533-09-2 C₃₁H₃₁Cl₂N₃O₃S 
• 1401533-10-5 C₃₁H₃₁ClFN₃O₃S 
• 1401532-91-9 C₂₆H₂₃Cl₂N₃OS 
• 1401532-92-0 C₂₆H₂₃ClFN₃OS 

Relevant articles and documents

Synthesis, crystal structures and luminescence properties of three new cadmium 3D coordination polymers

The new rigid planar ligand 2,5-bis(3-(pyridine-4-yl)phenyl)thiazolo[5,4-d]thiazole (BPPT) has been synthesized, which is an excellent building block for assembling coordination polymer. Under solvothermal reaction conditions, cadmium ion with BPPT in the

2-(aryl (azacycloalkane-1-yl) methyl) phenol derivatives and uses thereof

The invention discloses 2-(aryl (azacycloalkane-1-yl) methyl) phenol derivatives and application thereof, and belongs to the technical field of medicines. The invention provides a compound shown in a formula I or pharmaceutically acceptable salt thereof. The series of compounds have good inhibitory activity on the histone demethylase KDM4 family in vitro, the median inhibitory concentration (IC50) of most molecules on KDM4D is less than 500 nM, and the compounds have good inhibitory effect on proliferation of various human tumor cell strains in vitro, so that the series of compounds provide a new effective choice for developing targeted histone demethylase KDM4D drugs and preparing drugs for treating and/or preventing cancers and reproductive system diseases, and have good application prospects.

INSULIN SECRETION PROMOTING AGENTS

The present disclosure relates to novel compounds, compositions containing same and methods for treating or preventing a condition associated with a deficient insulin secretion such as diabetes and metabolic syndrome in a subject in need thereof.